Embracing AI in Clinical Trials: An Oncology CRO’s Insight
In our previous article, we outlined how AI may improve different areas of the oncology drug development process. The integration… [read more]
Read article
As a single-source provider for clinical trial planning, trial management and drug development planning, Medelis is helping biotechnology and pharmaceutical companies by delivering the best total solution—and all the support required—to optimize the return on your clinical research investments. And we accomplish that in the quickest, most responsive way possible.
Our approach is driven by a critical mass of clinical research expertise, the ability to identify and focus on the most significant challenges, and your need for prompt results.
Our world-class insight and experience in the development and execution of clinical research plans and protocols delivers the decision support you need to chart your next clinical move.
Medelis’ world-class medical and project teams have extensive experience in the design, performance and analysis of complex clinical trials.
Read MoreMedelis provides clinical research study design services, leveraging thought-leadership and the hands-on expertise of our clinical team to design your oncology study.
Read MoreMedelis provides oncology clinical research study launch services, as part of our full-service oncology CRO offering, for phase I and phase II studies.
Read MoreMedelis provides management for project management and clinical monitoring, medical monitoring, safety reporting, SAE narratives and document preparation.
Read MoreMedelis provides medical writing services from pre-IND through NDA. Our writers’ skills and experience present study results and clear, concise and polished documents.
Read MoreMedelis provides data management and biostatistics services as an oncology CRO for phase I through phase III clinical trials in North America and Europe.
Read MoreRescue studies are often challenging for any CRO, but Medelis has been entrusted with a number of rescue studies by its clients to get them back on track.
Read MoreIn addition to our full service oncology CRO offering, Medelis provides specialized oncology drug development consulting services in a number of different areas.
Read MoreMedelis can assist a non-U.S.-based company to gain access to the US drug study market by designing the plan for the pathway through the clinic.
Read MoreMedelis understands the challenges with oncology bioequivalence studies, including investigator selection, laboratory procedures and documentation.
Read MoreIn addition to our permanent operations in North America and Europe, we use a partnership model that enables us to execute trials as needed in almost any country.
This flexibility allows us to access the best sites and patient populations for specific trials while eliminating costly overhead and the need to maintain a network of offices around the globe.
In our previous article, we outlined how AI may improve different areas of the oncology drug development process. The integration… [read more]
Read articleThe release of GPT 3.5 and the improvement of large language models (LLMs) has captured the imagination of many around… [read more]
Read articleThe U.S. Food and Drug Administration (FDA) recently issued new guidance on the diversity of clinical trials, encouraging sponsors to… [read more]
Read article